Concepedia

Xiangyu Lv

XL

Statistics

Publications

5

Citations

221

H-Index

5

Active since

2019

Affiliations

Nanjing University of Chinese Medicine(Current)

China Pharmaceutical University

Xuzhou Medical College

Xiangyu Lv is an author at Nanjing University of Chinese Medicine specializing in life sciences, biochemistry, and inflammation.

Publications per year

2019–2021

5

Publications

5

Limonin ameliorates ulcerative colitis by regulating STAT3/miR-214 signaling pathway

Shijia Liu, Shufang Zhang, Xiangyu Lv et al. · International Immunopharmacology · 2019 · 84 citations

, , +12

Ginsenoside Rh2 alleviates ulcerative colitis by regulating the STAT3/miR-214 signaling pathway

Xuanqing Chen, Tingting Xu, Xiangyu Lv et al. · Journal of Ethnopharmacology · 2021 · 67 citations

, , +15

Untargeted serum metabolomics and potential biomarkers for Sjögren's syndrome

Tingting Xu, Yunke Guo, Jiawei Lu et al. · Clinical and Experimental Rheumatology · 2021 · 29 citations · Full text

, , +14

Discovery of Potential Serum Protein Biomarkers in Ankylosing Spondylitis Using Tandem Mass Tag-Based Quantitative Proteomics

Shijia Liu, Wei Ji, Jiawei Lu et al. · Journal of Proteome Research · 2020 · 24 citations

, , +17

Untargeted lipidomics reveals specific lipid abnormalities in Sjögren’s syndrome

Jiawei Lu, Yunke Guo, Yan Lu et al. · Lara D. Veeken · 2020 · 17 citations

, , +16

1–5 of 5